Nexity SA (LON:0KB3)
11.15
-0.40 (-3.46%)
At close: Aug 1, 2025
Intra-Cellular Therapies Revenue
Nexity had revenue of 1.30B EUR in the half year ending June 30, 2025, a decrease of -31.19%. This brings the company's revenue in the last twelve months to 3.05B, down -16.43% year-over-year. In the year 2024, Nexity had annual revenue of 3.33B, down -15.93%.
Revenue (ttm)
3.05B EUR
Revenue Growth
-16.43%
P/S Ratio
0.21
Revenue / Employee
857.25K EUR
Employees
3,562
Market Cap
536.78M USD
Revenue Chart
* This company reports financials in EUR.
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 3.33B | -631.36M | -15.93% |
Dec 31, 2023 | 3.96B | -387.44M | -8.90% |
Dec 31, 2022 | 4.35B | -116.62M | -2.61% |
Dec 31, 2021 | 4.47B | -43.28M | -0.96% |
Dec 31, 2020 | 4.51B | 310.92M | 7.40% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
AstraZeneca | 41.24B |
HSBC Holdings | 41.03B |
Shell | 198.54B |
Unilever | 51.24B |
British American Tobacco p.l.c. | 25.60B |
Rolls-Royce Holdings | 19.54B |
Rio Tinto Group | 39.22B |
RELX PLC | 9.53B |